PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33490645-0	2021	Ellagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all-trans retinoic acid-induced superoxide generating activity of U937 cells.	Ellagic Acid	0-12	cytochrome b-245 beta chain	Homo sapiens	85-94	
33490645-0	2021	Ellagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all-trans retinoic acid-induced superoxide generating activity of U937 cells.	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	45-56	cytochrome b-245 beta chain	Homo sapiens	85-94	
33490645-5	2021	Semiquantitative RT-PCR showed that transcription level of gp91-phox was certainly decreased (to ~70%) in ATRA plus ellagic acid-treated cells, while that of gp91-phox was significantly increased (to ~160%) in ATRA plus urolithin A-treated cells.	Tretinoin	106-110	cytochrome b-245 beta chain	Homo sapiens	59-68	
33490645-5	2021	Semiquantitative RT-PCR showed that transcription level of gp91-phox was certainly decreased (to ~70%) in ATRA plus ellagic acid-treated cells, while that of gp91-phox was significantly increased (to ~160%) in ATRA plus urolithin A-treated cells.	Ellagic Acid	116-128	cytochrome b-245 beta chain	Homo sapiens	59-68	
33490645-5	2021	Semiquantitative RT-PCR showed that transcription level of gp91-phox was certainly decreased (to ~70%) in ATRA plus ellagic acid-treated cells, while that of gp91-phox was significantly increased (to ~160%) in ATRA plus urolithin A-treated cells.	Ellagic Acid	116-128	cytochrome b-245 beta chain	Homo sapiens	158-167	
33490645-5	2021	Semiquantitative RT-PCR showed that transcription level of gp91-phox was certainly decreased (to ~70%) in ATRA plus ellagic acid-treated cells, while that of gp91-phox was significantly increased (to ~160%) in ATRA plus urolithin A-treated cells.	Tretinoin	210-214	cytochrome b-245 beta chain	Homo sapiens	59-68	
33490645-5	2021	Semiquantitative RT-PCR showed that transcription level of gp91-phox was certainly decreased (to ~70%) in ATRA plus ellagic acid-treated cells, while that of gp91-phox was significantly increased (to ~160%) in ATRA plus urolithin A-treated cells.	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	220-231	cytochrome b-245 beta chain	Homo sapiens	59-68	
33490645-6	2021	Chromatin immunoprecipitation assay suggested that urolithin A enhanced acetylations of Lys-9 residues of histone H3 within chromatin surrounding the promoter region of gp91-phox gene, but ellagic acid suppressed the acetylations.	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	51-62	cytochrome b-245 beta chain	Homo sapiens	169-178	
33490645-7	2021	Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%).	Tretinoin	34-38	cytochrome b-245 alpha chain	Homo sapiens	97-105	
33490645-7	2021	Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%).	Tretinoin	34-38	cytochrome b-245 beta chain	Homo sapiens	121-130	
33490645-7	2021	Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%).	Tretinoin	34-38	cytochrome b-245 alpha chain	Homo sapiens	217-225	
33490645-7	2021	Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%).	Tretinoin	34-38	cytochrome b-245 beta chain	Homo sapiens	240-249	
33490645-7	2021	Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%).	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	44-55	cytochrome b-245 alpha chain	Homo sapiens	97-105	
33490645-7	2021	Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%).	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	44-55	cytochrome b-245 beta chain	Homo sapiens	121-130	
33490645-7	2021	Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%).	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	44-55	cytochrome b-245 alpha chain	Homo sapiens	217-225	
33490645-7	2021	Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to ~160%) and gp91-phox (to ~170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to ~70%) and gp91-phox (to ~60%).	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	44-55	cytochrome b-245 beta chain	Homo sapiens	240-249	
33490645-8	2021	These results suggested that conversion of ellagic acid to urolithin A in gut may bring about reverse effects on the gp91-phox gene expression, resulting in opposite alterations in O2 --generating activity of intestinal macrophages.	Ellagic Acid	43-55	cytochrome b-245 beta chain	Homo sapiens	117-126	
33490645-8	2021	These results suggested that conversion of ellagic acid to urolithin A in gut may bring about reverse effects on the gp91-phox gene expression, resulting in opposite alterations in O2 --generating activity of intestinal macrophages.	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	59-70	cytochrome b-245 beta chain	Homo sapiens	117-126